Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa.
作者信息
Duga Alemayehu Lelisa, Ngongo Ngashi, Fallah Mosoka Papa, Figueras Albert, Kilowe Carlos, Murtala Jibril, Kayumba Kizito, Angasa Tedi, Kuba Aminu, Kabwe Patrick Chanda, Dereje Nebiyu, Raji Tajudeen, Ndembi Nicaise, Kaseya Jean
机构信息
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
Doctoral School Societies Politics, Public Health, Pharmacoepidemiology and Pharmacovigilance, University of Bordeaux, Bordeaux, France.
出版信息
BMJ Glob Health. 2024 Oct 9;9(10):e015445. doi: 10.1136/bmjgh-2024-015445.
Abstract
摘要
相似文献
1
Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa.疟疾疫苗在非洲开始推广：加强非洲监管和安全监测系统的必要性。
BMJ Glob Health. 2024 Oct 9;9(10):e015445. doi: 10.1136/bmjgh-2024-015445.
2
WHO's rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?世界卫生组织在非洲推广疟疾疫苗：仅24个月后就能解答安全问题吗？
BMJ. 2020 Jan 24;368:l6920. doi: 10.1136/bmj.l6920.
3
Malaria vaccination in Africa: A mini-review of challenges and opportunities.非洲的疟疾疫苗接种：挑战与机遇的小型综述。
Medicine (Baltimore). 2024 Jun 14;103(24):e38565. doi: 10.1097/MD.0000000000038565.
4
Setting up a data system for monitoring malaria vaccine introduction readiness and uptake in 42 health districts in Cameroon.在喀麦隆的 42 个卫生区建立一个数据系统，以监测疟疾疫苗引入准备情况和接种情况。
BMJ Glob Health. 2024 Apr 4;9(4):e015312. doi: 10.1136/bmjgh-2024-015312.
5
Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66.对参与疟疾疫苗SPf66安全性和免疫原性试点研究的冈比亚儿童的随访。
Parasite Immunol. 1997 Dec;19(12):579-81. doi: 10.1046/j.1365-3024.1997.d01-171.x.
6
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.在非洲不同传播环境下评估 RTS,S/AS01 疟疾疫苗在儿童中的疗效的 III 期多中心试验设计。
Malar J. 2011 Aug 4;10:224. doi: 10.1186/1475-2875-10-224.
7
Vaccines for malaria: how close are we?疟疾疫苗：我们还有多远？
Annu Rev Med. 2012;63:345-57. doi: 10.1146/annurev-med-022411-192402. Epub 2011 Nov 10.
8
First proven malaria vaccine rolled out in Africa - but doubts linger.首款经证实的疟疾疫苗在非洲推出——但质疑声犹存。
Nature. 2019 May;569(7754):14-15. doi: 10.1038/d41586-019-01342-z.
9
Malaria vaccines in Africa.
Acta Trop. 2003 Oct;88(2):153-9. doi: 10.1016/s0001-706x(03)00200-6.
10
Sustainable development of a GCP-compliant clinical trials platform in Africa: the malaria clinical trials alliance perspective.非洲符合 GCP 标准的临床试验平台的可持续发展：疟疾临床试验联盟的观点。
Malar J. 2010 Apr 20;9:103. doi: 10.1186/1475-2875-9-103.
本文引用的文献
1
Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries.42个非洲国家疟疾疫苗效力对疾病负担及耐药性的建模分析
Commun Med (Lond). 2023 Oct 13;3(1):144. doi: 10.1038/s43856-023-00373-y.
2
Drug safety in Africa: a review of systems and resources for pharmacovigilance.非洲的药物安全：药物警戒系统和资源综述。
Expert Opin Drug Saf. 2023 Jul-Dec;22(10):891-895. doi: 10.1080/14740338.2023.2251375. Epub 2023 Sep 7.
3
COVID-19 vaccine hesitancy in Africa: a scoping review.非洲的 COVID-19 疫苗犹豫：范围综述。
Glob Health Res Policy. 2022 Jul 19;7(1):21. doi: 10.1186/s41256-022-00255-1.
4
Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa.低、中收入国家的药物警戒：一项特别关注非洲的综述。
Br J Clin Pharmacol. 2023 Feb;89(2):491-509. doi: 10.1111/bcp.15193. Epub 2022 Feb 9.
5
Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.更安全的药物处方：PREFASEG 系统在加泰罗尼亚基层医疗中辅助临床决策的影响。
BMC Med Inform Decis Mak. 2021 Dec 15;21(1):349. doi: 10.1186/s12911-021-01710-8.
6
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance.国际药物警戒协会（ISoP）药物基因组学特别兴趣小组：药物警戒中的药物基因组学。
Drug Saf. 2021 Jun;44(6):615-617. doi: 10.1007/s40264-021-01068-w. Epub 2021 May 8.
7
Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.医疗产品监管协调：提高东非共同体监管能力的关键因素。
BMC Public Health. 2021 Jan 21;21(1):187. doi: 10.1186/s12889-021-10169-1.
8
The importance of effective risk communication and transparency: lessons from the dengue vaccine controversy in the Philippines.有效风险沟通和透明度的重要性：来自菲律宾登革热疫苗争议的教训。
J Public Health Policy. 2020 Sep;41(3):252-267. doi: 10.1057/s41271-020-00232-3.
9
Real-time vaccine safety surveillance for the early detection of adverse events.用于早期发现不良事件的实时疫苗安全性监测。
Med Care. 2007 Oct;45(10 Supl 2):S89-95. doi: 10.1097/MLR.0b013e3180616c0a.
Zotero 插件